Literature DB >> 2085441

Conditioned medium from mouse sarcoma 180 cells contains vascular endothelial growth factor.

R A Rosenthal1, J F Megyesi, W J Henzel, N Ferrara, J Folkman.   

Abstract

Medium conditioned by mouse sarcoma 180 cells stimulates the growth of capillary endothelial cells. The growth factor produced by mouse sarcoma 180 cells is heparin-binding, dithiothreitol-sensitive, endothelial cell specific, and secreted into the medium. The characteristics of this mouse sarcoma-derived growth factor are very similar to those of vascular endothelial growth factor (VEGF) first described by Ferrara and Henzel (1989). The N-terminal amino acid sequences of the two growth factors are similar. Since the amino acid sequence of vascular permeability factor (VPF) is essentially identical to that of VEGF, a Western blot of mouse sarcoma 180-derived endothelial growth factor was probed with a polyclonal antibody raised against human VPF. This antibody reacted with several proteins of approximately 23 kDa, suggesting the presence of multiple forms of a VEGF-like protein. A full length cDNA probe for bovine VEGF reacted strongly with RNA isolated from mouse sarcoma 180 cells. We conclude that an endothelial growth factor found in conditioned medium from mouse sarcoma 180 cells is VEGF.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2085441     DOI: 10.3109/08977199009011010

Source DB:  PubMed          Journal:  Growth Factors        ISSN: 0897-7194            Impact factor:   2.511


  23 in total

1.  B lymphocyte-specific c-Myc expression stimulates early and functional expansion of the vasculature and lymphatics during lymphomagenesis.

Authors:  Alanna Ruddell; Pau Mezquita; Kimberly A Brandvold; Andrew Farr; Brian M Iritani
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

Review 2.  A systems approach to cancer therapy. (Antioncogenics + standard cytotoxics-->mechanism(s) of interaction).

Authors:  B A Teicher
Journal:  Cancer Metastasis Rev       Date:  1996-06       Impact factor: 9.264

3.  Binding sites for vascular endothelial growth factor are localized on endothelial cells in adult rat tissues.

Authors:  L B Jakeman; J Winer; G L Bennett; C A Altar; N Ferrara
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

4.  Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor.

Authors:  R L Kendall; K A Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-15       Impact factor: 11.205

Review 5.  Lymphangiogenesis: a new player in cancer progression.

Authors:  Masayuki Nagahashi; Subramaniam Ramachandran; Omar M Rashid; Kazuaki Takabe
Journal:  World J Gastroenterol       Date:  2010-08-28       Impact factor: 5.742

6.  Normoxic wound fluid contains high levels of vascular endothelial growth factor.

Authors:  T R Howdieshell; C Riegner; V Gupta; D Callaway; K Grembowicz; P L McNeil
Journal:  Ann Surg       Date:  1998-11       Impact factor: 12.969

7.  Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms.

Authors:  R A Berkman; M J Merrill; W C Reinhold; W T Monacci; A Saxena; W C Clark; J T Robertson; I U Ali; E H Oldfield
Journal:  J Clin Invest       Date:  1993-01       Impact factor: 14.808

8.  Vascular endothelial growth factor and the collateral circulation: the story continues.

Authors:  William M Chilian; Yuh Fen Pung
Journal:  Circ Res       Date:  2008-10-24       Impact factor: 17.367

Review 9.  The role of vascular endothelial growth factor in pathological angiogenesis.

Authors:  N Ferrara
Journal:  Breast Cancer Res Treat       Date:  1995       Impact factor: 4.872

10.  Expression of vascular endothelial growth factor and presence of angiovascular cells in tissues from different thyroid disorders.

Authors:  Asako Itoh; Katsumi Iwase; Shin Jimbo; Haruo Yamamoto; Naoki Yamamoto; Masahiro Kokubo; Takao Senda; Akira Nakai; Akio Nagagasaka; Takaaki Nagasaka; Yatsuka Hibi; Teppei Seko
Journal:  World J Surg       Date:  2010-02       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.